Real-world data on guselkumab, especially at times >6 months, are limited.
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Hansel, KatharinaConceptualization
;Papini, Manuela;Stingeni, LucaConceptualization
;
2022
Abstract
Real-world data on guselkumab, especially at times >6 months, are limited.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
